{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:48:07Z","timestamp":1761155287201},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,6,27]],"date-time":"2009-06-27T00:00:00Z","timestamp":1246060800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1007\/s10549-009-0446-6","type":"journal-article","created":{"date-parts":[[2009,6,26]],"date-time":"2009-06-26T06:19:16Z","timestamp":1245997156000},"page":"385-394","source":"Crossref","is-referenced-by-count":27,"title":["Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure"],"prefix":"10.1007","volume":"118","author":[{"given":"E.","family":"Montagna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Viale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Rotmensz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Maisonneuve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Galimberti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Luini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Intra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Veronesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Mazzarol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Pruneri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Renne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Torrisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Cardillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Cancello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Goldhirsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Colleoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,6,27]]},"reference":[{"key":"446_CR1","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1200\/JCO.2005.07.094","volume":"23","author":"M Colleoni","year":"2005","unstructured":"Colleoni M, Rotmensz N, Perruzzotti G et al (2005) Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement. J Clin Oncol 23:1379\u20131389","journal-title":"J Clin Oncol"},{"key":"446_CR2","first-page":"1565","volume":"335","author":"International (Ludwig) Breast Cancer Study Group","year":"1990","unstructured":"International (Ludwig) Breast Cancer Study Group (1990) Prognostic importance of occult axillary lymph node micrometastases from breast cancer. Lancet 335:1565\u20131568","journal-title":"Lancet"},{"issue":"12","key":"446_CR3","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.ejca.2008.05.011","volume":"44","author":"PT Truong","year":"2008","unstructured":"Truong PT, Vinh-Hung V, Cserni G et al (2008) The number of positive nodes and the ratio of positive to excised nodes are significant predictors of survival in women with micrometastatic node-positive breast cancer. Eur J Cancer 44(12):1670\u20131677","journal-title":"Eur J Cancer"},{"issue":"12","key":"446_CR4","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1245\/s10434-007-9513-6","volume":"14","author":"SL Chen","year":"2007","unstructured":"Chen SL, Hoehne FM (2007) The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis. Ann Sur Oncol 14(12):3378\u20133384","journal-title":"Ann Sur Oncol"},{"key":"446_CR5","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ejso.2006.04.001","volume":"32","author":"M van der Heiden-van der Loo","year":"2006","unstructured":"van der Heiden-van der Loo M, Bezemer PD, Hennipman A et al (2006) Introduction of sentinel node biopsy and stage migration of breast cancer. Eur J Surg Oncol 32:710\u2013714","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"446_CR6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/cncr.22069","volume":"107","author":"MC Rijk van","year":"2006","unstructured":"van Rijk MC, Peterse JL, Nieweg OE et al (2006) Additional axillary metastases or submicrometastases in sentinel lymph nodes. Cancer 107(3):467\u2013471","journal-title":"Cancer"},{"issue":"2","key":"446_CR7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/A:1012938825396","volume":"70","author":"VC Tjan-Heijnen","year":"2001","unstructured":"Tjan-Heijnen VC, Bult P, de Widt-Evert LM et al (2001) Micro-metastases in axillary lymph nodes: an increasing classification and treatment dilemma in breast cancer due to the introduction of the sentinel lymph node procedure. Breast Cancer Res Treat 70(2):81\u201388","journal-title":"Breast Cancer Res Treat"},{"key":"446_CR8","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/S0140-6736(97)01004-0","volume":"349","author":"U Veronesi","year":"1997","unstructured":"Veronesi U, Paganelli G, Galimberti V et al (1997) Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 349:1864\u20131867","journal-title":"Lancet"},{"key":"446_CR9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1365-2559.2002.14691.x","volume":"41","author":"CW Elston","year":"2002","unstructured":"Elston CW, Ellis IO (2002) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer-Experience from a large study with long-term follow-up. Histopathology 41:151","journal-title":"Histopathology"},{"key":"446_CR10","volume-title":"Tumors of the mammary gland","author":"PP Rosen","year":"1993","unstructured":"Rosen PP, Oberman H (1993) Tumors of the mammary gland. Armed Forces Institute of Pathology, Washington"},{"key":"446_CR11","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0959-8049(99)00005-2","volume":"35","author":"M Colleoni","year":"1999","unstructured":"Colleoni M, Orvieto E, Nol\u00e8 F et al (1999) Prediction of response to primary chemotherapy for operable breast cancer. Eur J Cancer 35:574\u2013579","journal-title":"Eur J Cancer"},{"key":"446_CR12","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1200\/JCO.2002.02.026","volume":"20","author":"SE Singletary","year":"2002","unstructured":"Singletary SE, Allred C, Ashley P et al (2002) Revision of the American Joint Committee on cancer staging system for breast cancer. J Clin Oncol 20:3628\u20133636","journal-title":"J Clin Oncol"},{"key":"446_CR13","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJMoa012782","volume":"349","author":"U Veronesi","year":"2003","unstructured":"Veronesi U, Paganelli G, Viale G et al (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349:546\u2013553","journal-title":"N Engl J Med"},{"key":"446_CR14","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/cncr.20535","volume":"101","author":"R Gennari","year":"2004","unstructured":"Gennari R, Curigliano G, Rotmensz N et al (2004) Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger postmenopausal patients. Cancer 101:1302\u20131310","journal-title":"Cancer"},{"key":"446_CR15","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/jnci\/87.19.1441","volume":"87","author":"A Goldhirsch","year":"1995","unstructured":"Goldhirsch A, Wood WC, Senn HJ et al (1995) Meeting highlights: International Consensus Panel on the treatment of primary breast cancer. J Natl Cancer Inst 87:1441\u20131445","journal-title":"J Natl Cancer Inst"},{"key":"446_CR16","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/jnci\/90.21.1601","volume":"90","author":"A Goldhirsch","year":"1998","unstructured":"Goldhirsch A, Glick JH, Gelber RD et al (1998) Meeting highlights: International consensus panel on the treatment of primary breast cancer. J Natl Cancer Inst 90:1601\u20131608","journal-title":"J Natl Cancer Inst"},{"key":"446_CR17","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1038\/sj.bjc.6600334","volume":"86","author":"M Colleoni","year":"2002","unstructured":"Colleoni M, Liman HJ, Castiglione-Gertsch M et al (2002) Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF. Br J Cancer 86:1705\u20131714","journal-title":"Br J Cancer"},{"key":"446_CR18","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1200\/JCO.1990.8.9.1483","volume":"8","author":"B Fisher","year":"1990","unstructured":"Fisher B, Brown AM, Dimitrov NV et al (1990) Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6\u00a0months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project B 15. J Clin Oncol 8:1483\u20131496","journal-title":"J Clin Oncol"},{"key":"446_CR19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00000658-197101000-00006","volume":"173","author":"AG Huvos","year":"1971","unstructured":"Huvos AG, Hutter R (1971) Significance of axillary macrometastases and micrometastases in mammary cancer. Ann Surg 173:44\u201346","journal-title":"Ann Surg"},{"key":"446_CR20","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/1097-0142(194807)1:2<238::AID-CNCR2820010208>3.0.CO;2-U","volume":"1","author":"O Saphir","year":"1948","unstructured":"Saphir O, Amromin GD (1948) Obscure axillary lymph node metastases in carcinoma of the breast. Cancer 1:238\u2013241","journal-title":"Cancer"},{"key":"446_CR21","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/bjs.1800800417","volume":"80","author":"PJ Hainsworth","year":"1993","unstructured":"Hainsworth PJ, Tjandra JJ, Stillwell RG et al (1993) Detection and significance of occult metastases in node negative breast cancer. Br J Surg 80:459\u2013463","journal-title":"Br J Surg"},{"key":"446_CR22","first-page":"24","volume":"20","author":"MN Hansen","year":"2001","unstructured":"Hansen MN, Grube BJ, Te W et al (2001) Clinical significance of axillary micrometastases in breast cancer: how small is too small? Proc Am Soc Clin Oncol 20:24 abstr 91","journal-title":"Proc Am Soc Clin Oncol"},{"key":"446_CR23","doi-asserted-by":"crossref","unstructured":"De Boer M, van Deurzen CH, van Dijck JA et al. (2009) Micrometastases and isolated tumors cells: relevant and robust or rubbish? (MIRROR): preliminary results of the MIRROR study from the Dutch breast cancer trialists group (BOOG). Cancer Res 69(Suppl 2):70s abstr 23","DOI":"10.1158\/0008-5472.SABCS-23"},{"issue":"1","key":"446_CR24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/annonc\/mdn535","volume":"20","author":"PD Gobardhan","year":"2009","unstructured":"Gobardhan PD, Elias SG, Madsen EVE et al (2009) Prognostic value of micrometastases in sentinel lymph nodes of patients with breast carcinoma: a cohort study. Ann Oncol 20(1):41\u201348","journal-title":"Ann Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-009-0446-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-009-0446-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-009-0446-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T16:32:18Z","timestamp":1559233938000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-009-0446-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,27]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["446"],"URL":"https:\/\/doi.org\/10.1007\/s10549-009-0446-6","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,27]]}}}